ITGB3 and invasive breast carcinoma: Although two later case–control studies did not confirm an increased risk of invasive breast cancer among Leu33Pro homozygotes (Ayala et al, 2003; Jin et al, 2004), certain considerations nevertheless favour the possibility that the ITGB3 Leu33Pro polymorphism may influence risk of invasive breast cancer.